论文信息 - Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient - 字舞流文

Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient

A. Camargo | A. Shimada | F. Bettoni | F. Knebel | A. Katz | J. Alessi | K. P. Sacardo | M. Ribeiro | J. Marin | F. Canedo | Rodrigo Saddi | M. F. Ribeiro